Featured cardiac surgery products

VitalFlow™ ECMO system

Designed for simplicity and performance, the VitalFlow™ ECMO system can be configured to accommodate your clinical preferences and hospital protocols.1

This is an image of the Avalus Ultra™ bioprosthesis, a next-generation bovine pericardial valve with a circular base frame and AOA tissue treatment for aortic valve replacement.

Avalus Ultra™ bioprosthesis

Built on the Avalus™ platform that leads in evidence and excels in performance — the Avalus Ultra™ valve facilitates ease at implant2 and is designed to deliver long-term durability with its industry-leading EOAs3,4 and circular design engineered for lifetime patient management.

Penditure™ LAA exclusion system

The Penditure™ device is used for the exclusion of the left atrial appendage in patients undergoing a concomitant cardiac surgery procedure. It is the only LAA clip that can be recaptured, repositioned, and redeployed after deployment during a procedure, putting greater control in the hands of surgeons.5









Medtronic Cardiac Surgery

With every beat, expect more.



Potential complications related to the use of ECMO devices include, but are not limited to, heart, vessel, or lung damage, hypoxia, anemia, irritation, toxic reaction, infection, hemorrhage, liver or kidney failure, stroke, and death. The benefits of extracorporeal support must be weighed against the risk of systemic anticoagulation and must be assessed by the prescribing physician.

Surgical valve replacement risks may include infection, surgical complications, stroke, endocarditis and death.

Possible complications related to the use of Penditure™ LAA exclusion system in combination with open heart surgery are: bleeding, tissue damage, thromboembolism, and pericardial effusion.


  1. Medtronic design verification data on file. Data may not be indicative of clinical performance.
  2. Based on internal test report (D00998354), Avalus Ultra™ HFE design validation test report.
  3. Sabik JF III, Rao V, Dagenais F, et al. 7-year outcomes after surgical aortic valve replacement with a stented bovine pericardial bioprosthesis in over 1100 patients: a prospective multicenter analysis. Eur J Cardiothorac Surg. December 26, 2024;67(1):ezae414.
  4. Klautz RJM, Rao V, Reardon MJ, et al. Examining the typical hemodynamic performance of nearly 3000 modern surgical aortic bioprostheses. Eur J Cardiothorac Surg. 2024;65(5):ezae122. doi:10.1093/ejcts/ezae122.
  5. Medtronic design verification data on file. Data may not be indicative of clinical performance.